{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:59:14Z","timestamp":1788793154245,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12032-021-01550-6","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T10:02:48Z","timestamp":1627984968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue?"],"prefix":"10.1007","volume":"38","author":[{"given":"Riccardo Ray","family":"Colciago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Vitullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6783-710X","authenticated-orcid":false,"given":"Eliana","family":"La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Giandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bonfantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Di Cosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Baili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Sant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Pignoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Valdagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmen","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"issue":"9804","key":"1550_CR1","first-page":"1707e16","volume":"378","author":"S Darby","year":"2011","unstructured":"Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials. Lancet. 2011;378(9804):1707e16.","journal-title":"Lancet"},{"key":"1550_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513\u201320.","journal-title":"N Engl J Med"},{"key":"1550_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","volume":"9","author":"SM Bentzen","year":"2008","unstructured":"Bentzen SM, Agrawal RK, START Trialists\u2019 Group, et al. The UK standardisation of breast radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9:331\u201341.","journal-title":"Lancet Oncol"},{"key":"1550_CR4","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","volume":"371","author":"SM Bentzen","year":"2008","unstructured":"Bentzen SM, Agrawal RK, START Trialists\u2019 Group, et al. The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098\u2013107.","journal-title":"Lancet"},{"key":"1550_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","volume":"8","author":"BD Smith","year":"2018","unstructured":"Smith BD, Bellon JR, Blitzblau R, et al. Radiation therapy for the whole breast: executive summary of an American society for radiation oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018;8:145\u201352.","journal-title":"Pract Radiat Oncol"},{"key":"1550_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.radonc.2020.10.008","volume":"155","author":"I Ratosa","year":"2020","unstructured":"Ratosa I, Chiril\u0103 ME, Steinacher M, et al. Hypofractionated radiation therapy for breast cancer: preferences amongst radiation oncologists in Europe\u2014results from an international survey. Radiother Oncol. 2020;155:17\u201326. https:\/\/doi.org\/10.1016\/j.radonc.2020.10.008 (Online ahead of print).","journal-title":"Radiother Oncol"},{"key":"1550_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2478\/raon-2018-0026","volume":"52","author":"I Ratosa","year":"2018","unstructured":"Ratosa I, Jenko A, Oblak I. Breast size impact on adjuvant radiotherapy adverse effects and dose parameters in treatment planning. Radiol Oncol. 2018;52:233\u201344.","journal-title":"Radiol Oncol"},{"key":"1550_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0167-8140(94)90063-9","volume":"33","author":"AM Moody","year":"1994","unstructured":"Moody AM, Mayles WP, Bliss JM, et al. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol. 1994;33:106\u201312.","journal-title":"Radiother Oncol"},{"key":"1550_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0936-6555(05)81031-3","volume":"3","author":"JD Brierley","year":"1991","unstructured":"Brierley JD, Paterson IC, Lallemand RC, Rostom RY. The influence of breast size on late radiation reaction following excision and radiotherapy for early breast cancer. Clin Oncol (R Coll Radiol). 1991;3:6\u20139.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1550_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0360-3016(91)90781-X","volume":"21","author":"JR Gray","year":"1991","unstructured":"Gray JR, McCormick B, Cox L, Yahalom J. Primary breast irradiation in large-breasted or heavy women: analysis of cosmetic outcome. Int J Radiat Oncol Biol Phys. 1991;21:347\u201354.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1550_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1200\/JCO.2004.07.174","volume":"22","author":"TE Goffman","year":"2004","unstructured":"Goffman TE, Glatstein E. Hypofractionation redux? J Clin Oncol. 2004;22:589\u201391.","journal-title":"J Clin Oncol"},{"key":"1550_CR12","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/S0360-3016(02)03746-X","volume":"54","author":"FA Vicini","year":"2002","unstructured":"Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2002;54:1336\u201344.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1550_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.meddos.2013.12.003","volume":"39","author":"A Michalski","year":"2014","unstructured":"Michalski A, Atyeo J, Cox J, Rinks M, Morgia M, Lamoury G. A dosimetric comparison of 3D-CRT, IMRT, and static tomotherapy with a SIB for large and small breast volumes. Med Dosim. 2014;39:163\u20138.","journal-title":"Med Dosim"},{"key":"1550_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijrobp.2008.04.036","volume":"73","author":"VJ Croog","year":"2009","unstructured":"Croog VJ, Wu AJ, McCormick B, Beal KP. Accelerated whole breast irradiation with intensity-modulated radiotherapy to the prone breast. Int J Radiat Oncol Biol Phys. 2009;73:88\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1550_CR15","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","volume":"26","author":"JP Pignol","year":"2008","unstructured":"Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26:2085\u201392.","journal-title":"J Clin Oncol"},{"key":"1550_CR16","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0360-3016(99)00132-7","volume":"44","author":"L Hong","year":"1999","unstructured":"Hong L, Hunt M, Chui C, et al. Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys. 1999;44:1155\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1550_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.radonc.2006.12.008","volume":"82","author":"E Donovan","year":"2007","unstructured":"Donovan E, Bleakley N, Denholm E, et al. Breast technology. Group randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radio-therapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol. 2007;82:254\u201364.","journal-title":"Radiother Oncol"},{"key":"1550_CR18","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1200\/JCO.2006.09.1041","volume":"25","author":"SC Formenti","year":"2007","unstructured":"Formenti SC, Gidea-Addeo D, Goldberg JK, et al. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol. 2007;25:2236\u201342.","journal-title":"J Clin Oncol"},{"issue":"31","key":"1550_CR19","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1200\/JCO.20.01363","volume":"38","author":"BV Offersen","year":"2020","unstructured":"Offersen BV, Alsner J, Nielsen HM, et al. Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial; the DBCG HYPO trial. J Clin Oncol. 2020;38(31):3615\u201325.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1550_CR20","doi-asserted-by":"publisher","first-page":"3e10","DOI":"10.1016\/j.radonc.2014.11.030","volume":"114","author":"BV Offersen","year":"2015","unstructured":"Offersen BV, Boersma LJ, Kirkove C, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early-stage breast cancer. Radiother Oncol. 2015;114(1):3e10.","journal-title":"Radiother Oncol"},{"issue":"30","key":"1550_CR21","doi-asserted-by":"publisher","first-page":"4939e47","DOI":"10.1200\/JCO.2008.21.5764","volume":"27","author":"HA Jones","year":"2009","unstructured":"Jones HA, Antonini N, Hart AA, et al. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol. 2009;27(30):4939e47.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1550_CR22","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"1550_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell","year":"1996","unstructured":"Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361\u201387.","journal-title":"Stat Med"},{"key":"1550_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","author":"BE Hickey","year":"2016","unstructured":"Hickey BE, James ML, Lehman M, et al. Hypofractionated radiation therapy for early breast cancer. Cochrane Database Syst Rev. 2016. https:\/\/doi.org\/10.1002\/14651858.","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 3","key":"1550_CR25","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.21037\/atm.2019.06.26","volume":"7","author":"P Franco","year":"2019","unstructured":"Franco P, Bartoncini S, Martini S, Iorio GC, Richard U. Do hypofraction and large breast size reciprocally fit in breast cancer radiotherapy? Ann Transl Med. 2019;7(Suppl 3):S146. https:\/\/doi.org\/10.21037\/atm.2019.06.26.","journal-title":"Ann Transl Med"},{"issue":"3","key":"1550_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11604-011-0034-7","volume":"30","author":"C Onal","year":"2012","unstructured":"Onal C, Sonmez A, Arslan G, Oymak E, Kotek A, Efe E, Sonmez S, Dolek Y. Dosimetric comparison of the field-in-field technique and tangential wedged beams for breast irradiation. Jpn J Radiol. 2012;30(3):218\u201326. https:\/\/doi.org\/10.1007\/s11604-011-0034-7.","journal-title":"Jpn J Radiol"},{"key":"1550_CR27","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ijrobp.2012.01.093","volume":"84","author":"R Hannan","year":"2012","unstructured":"Hannan R, Thompson RF, Chen Y, et al. Hypofractionated whole-breast radiation therapy: does breast size matter? Int J Radiat Oncol Biol Phys. 2012;84:894\u2013901.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1550_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/COC.0b013e31827b45b7","volume":"37","author":"KS Corbin","year":"2014","unstructured":"Corbin KS, Dorn PL, Jain SK, et al. Hypofractionated radiotherapy does not increase scute toxicity in large-breasted women: results from a prospectively collected series. Am J Clin Oncol. 2014;37:322\u20136.","journal-title":"Am J Clin Oncol"},{"key":"1550_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijrobp.2018.08.024","volume":"103","author":"AK Patel","year":"2019","unstructured":"Patel AK, Ling DC, Richman AH, et al. Hypofractionated whole-breast irradiation in large-breasted women\u2014is there a dosimetric predictor for acute skin toxicities? Int J Radiat Oncol Biol Phys. 2019;103:71\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1550_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.clbc.2020.06.005","volume":"20","author":"F De Rose","year":"2020","unstructured":"De Rose F, Fogliata A, Franceschini D, et al. Hypofractionated whole breast irradiation and simultaneous integrated boost in large-breasted patients: long-term toxicity and cosmesis. Clin Breast Cancer. 2020;20(6):527\u201333. https:\/\/doi.org\/10.1016\/j.clbc.2020.06.005.","journal-title":"Clin Breast Cancer"},{"key":"1550_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.breast.2016.07.013","volume":"29","author":"MC De Santis","year":"2016","unstructured":"De Santis MC, Bonfantini F, Di Salvo F, et al. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy. Breast. 2016;29:90\u20135. https:\/\/doi.org\/10.1016\/j.breast.2016.07.013.","journal-title":"Breast"},{"issue":"7","key":"1550_CR32","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s00432-020-03243-5","volume":"146","author":"E La Rocca","year":"2020","unstructured":"La Rocca E, Meneghini E, Lozza L, et al. Older age and comorbidity in breast cancer: is RT alone the new therapeutic frontier? J Cancer Res Clin Oncol. 2020;146(7):1791\u2013800. https:\/\/doi.org\/10.1007\/s00432-020-03243-5.","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-021-01550-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-021-01550-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-021-01550-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T06:47:46Z","timestamp":1629787666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-021-01550-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1550"],"URL":"https:\/\/doi.org\/10.1007\/s12032-021-01550-6","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"assertion":[{"value":"20 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that we do not have any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study has been reviewed and approved by the Internal Review Board of the Department of Radiation Oncology 1 of National Cancer Institute, Milan, Italy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving in human and animal rights"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"107"}}